ALL |
Acute Lymphoblastic Leukemia |
BC |
Breast cancer |
BMAL1 |
Brain and muscle arnt-like 1 |
C- |
C-terminal |
CCN (A/B/D/E) |
Cell cyclin (A/B/D/E) |
CDK |
Cyclin-dependent kinase |
CLPs |
Common lymphatic progenitor cells |
CRLs |
Cullin-RING ligases |
DLBCL |
Diffuse large B-cell lymphoma |
DUB |
Deubiquitinating enzyme |
E2 |
Ubiquitin-conjugating enzyme |
EBV |
Epstein-Barr virus |
ERAD |
Endoplasmic reticulum-associated degradation |
FA |
Fanconi |
GBM |
Glioblastoma |
HCC |
Hepatocellular carcinoma |
HR |
Homologous recombination |
ICL |
Interstrand cross-link |
IKK |
IκB kinase |
LC |
Lung cancer |
LUBAC |
Linear ubiquitin chain assembly complex |
mES |
Mouse embryonic stem cells |
MM |
Multiple myeloma |
MMP |
Matrix metalloprotinase |
N- |
N-terminal |
NF-κB |
Nuclear factor-kappa B |
NIK |
NF-κB inducing kinase |
NSCLC |
Non-small cell lung cancer |
OSCC |
Oral squamous cell carcinoma |
PCa |
Prostate cancer |
PCNA |
Proliferating cell nuclear antigen |
polyUb |
Polyubiquitin |
RING |
Really interesting new gene |
RPs |
Ribosomal proteins |
SCF |
SKP1/CUL1/F-box protein complex |
TLS |
Translesion synthesis |
TNF-α |
Tumor necrosis factor α |
βTrCP |
β-transducin repeat-containing protein |
Ub |
Ubiquitin |
Ubl |
Ub-like |
APC/C |
Anaphase-promoting complex/cyclosome |
BCL2 |
B-cell leukemia/lymphoma 2 |
BRCA1 |
Breast cancer 1 |
CC |
Colon cancer |
CDC20 |
Cell division cycle 20 |
CDKN1A/p21/Cip1 |
Cyclin dependent kinase inhibitor 1A |
CRC |
Colorectal cancer |
DDP |
Cisplatin |
DSBR |
DNA Double strand break repair |
E1 |
Ubiquitin activating enzyme |
E3 |
Ubiquitin ligase |
EMT |
Epithelial to mesenchyme transition |
ERK |
Extracellular regulated protein kinases |
FOXM1 |
Forkhead box protein M1 |
GC |
Gastric cancer |
HNSCC |
Head and neck squamous cell carcinoma |
IAPs |
Inhibitor of apoptosis proteins |
ICT |
Icaritin |
IκB |
Inhibitor of nuclear factor kappa B |
LCSCs |
Liver cancer stem cell |
MDM2 |
Mouse double minute 2 homolog |
miRNAs |
microRNAs |
MMC |
Mitomycin C |
MXI1 |
Max-interacting protein 1 |
NB |
Neuroblastoma |
NHEJ |
Non-homologous end joining |
NPC |
Nasopharyngeal carcinoma |
OC |
Ovarian cancer |
p27Kip1
|
Kinase inhibition protein p27 |
PCGF2 |
Polycomb group ring finger 2 |
PML-RARA |
Promyelocytic leukemia (PML) and the retinoic acid receptor-α (RARA) |
RC |
Renal carcinoma |
RIP1 |
Receptor-interacting protein 1 |
SAC |
Spindle-assembly checkpoint |
SUMO |
Small ubiquitin-like modifier |
TNBC |
Triple negative breast cancer |
TRAF |
TNF receptor associated factor |
TSCC |
Tongue Squamous Cell Carcinoma |
UBC |
Ubiquitin-conjugating |
UPP |
Ubiquitin-Proteasome Pathway |